Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion type Assertion NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_head.
- NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion description "[These findings indicate that miR-155 has a pivotal role in tumour angiogenesis by downregulation of VHL, and provide a basis for miR-155-expressing tumours to embody an aggressive malignant phenotype, and therefore miR-155 is an important therapeutic target in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_provenance.
- NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion evidence source_evidence_literature NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_provenance.
- NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion SIO_000772 23353819 NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_provenance.
- NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion wasDerivedFrom befree-2016 NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_provenance.
- NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_assertion wasGeneratedBy ECO_0000203 NP1047418.RA4U5m3JflDdEzYWLNl1c-J88wwRLu6y8-09-JowjYVgM130_provenance.